Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2025-12-16 @ 9:28 PM
Study NCT ID:
NCT05814627
Status:
None
Last Update Posted:
2025-12-12 00:00:00
First Post:
2023-04-04 00:00:00
Brief Title:
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
Sponsor:
AbbVie
Organization:
AbbVie
Organization Data
Organization:
AbbVie
Class:
INDUSTRY
Study ID:
M23-700
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AbbVie
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None